Top Story

PCON to sponsor academy plenary on cannabinoids

October 8, 2014

The plenary session at this year’s American Academy of Optometry annual meeting will explore the health benefits and risks of cannabinoids, and Primary Care Optometry News will provide partial sponsorship of the event.

The use of marijuana, both as a recreational drug and for medical treatment, is one of today’s most hotly debated topics.

figure Meeting News CoverageVideo

Hom shares resources available for generic drugs

September 20, 2014
Milton Hom, OD, says the FDA has an online resource on generics and also discusses how older agents are now effective against new bacteria.Disclosure: Hom has no…
FDA News

Herantis Pharma pursues phase 2 study for dry eye treatment

September 15, 2014
The U.S. Food and Drug Administration has cleared the Investigational New Drug application of Herantis Pharma for a phase 2 clinical study of Cis-UCA eye drops for dry…
In the Journals

Hyaluronic acid useful in drug-releasing lenses

September 9, 2014
The addition of hyaluronic acid increased drug loading and release mass in silicone hydrogel contact lenses, according to a study recently published in Eye &
CME
figure

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
figure

Hom shares resources available for generic drugs

September 20, 2014
Milton Hom, OD, says the FDA has an online resource on generics and also discusses how older agents are now effective…
More »

Filter By:

PCON to sponsor academy plenary on cannabinoids

October 8, 2014
The plenary session at this year’s American Academy of Optometry annual meeting will explore the health benefits and risks of cannabinoids…
figure Meeting News Coverage Video

Hom shares resources available for generic drugs

September 20, 2014
Milton Hom, OD, says the FDA has an online resource on generics and also discusses how older agents are now effective against new…
FDA News

Herantis Pharma pursues phase 2 study for dry eye treatment

September 15, 2014
The U.S. Food and Drug Administration has cleared the Investigational New Drug application of Herantis Pharma for a phase 2 clinical study of Cis-UCA…
In the Journals

Hyaluronic acid useful in drug-releasing lenses

September 9, 2014
The addition of hyaluronic acid increased drug loading and release mass in silicone hydrogel contact lenses, according to a study recently published…

Efficacy primary consideration with adjunctive therapies, survey finds

September 4, 2014
The majority of glaucoma specialists reported that efficacy was most important when prescribing adjunctive therapies for glaucoma when compared to…
figure Commentary

Clinicians should openly discuss concerns over generics with patients

Primary Care Optometry News, October 2014
Agustin L. Gonzalez, OD; Melvin Friedman, OD, FAAO
The idea that generic drugs are equivalent to brand-name medications is based on a lack of understanding of U.S. Food and Drug Administration…
figure PCON CE

Numerous therapies exist to control IOP, delay glaucoma progression

Primary Care Optometry News, October 2014
Dina Erickson, OD, FAAO; Garrett R. Scott, MD; Len V. Koh, MBA OD, PhD, FAAO
Glaucoma, a word derived from the Greek “glaukos,” appeared in the works of Homer around the 8th century BC, describing a sparkling…
Perspectives on Glaucoma

Fixed combination lowers IOP better than monotherapy

August 22, 2014
A fixed combination of brinzolamide 1% and brimonidine 0.2% was more effective than brimonidine or brinzolamide alone in lowering intraocular…
Perspectives on Glaucoma Perspective

Study: Brimonidine significantly reduces daytime IOP

July 25, 2014
Utilization of brimonidine in a seated position significantly lowered intraocular pressure by increasing uveoscleral outflow, according to a recent…
PCON Reports

Drug-eluting contacts years away from market, researchers say

Primary Care Optometry News, July 2014
Drug-eluting contact lenses have been discussed as a potential treatment modality for decades but have yet to reach patients. To those researching…
More Headlines »